BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1680945)

  • 21. [Coexistence of peptides and classical neurotransmitters].
    Pelletier G
    Ann Endocrinol (Paris); 1984; 45(3):173-4. PubMed ID: 6084453
    [No Abstract]   [Full Text] [Related]  

  • 22. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biochemical aspects of the mechanism of action of cholinolytics on the brain].
    Krylov SS; Semenov EV
    Usp Sovrem Biol; 1982; 93(3):397-408. PubMed ID: 6126054
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemistry of the basal ganglia.
    Fahn S
    Adv Neurol; 1976; 14():59-89. PubMed ID: 7932
    [No Abstract]   [Full Text] [Related]  

  • 25. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemistry of dementia.
    Whitehouse PJ; Unnerstall JR
    Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms in the regulation of neurotransmitter release from brain nerve terminals: current hypotheses.
    Sihra TS; Nichols RA
    Neurochem Res; 1993 Jan; 18(1):47-58. PubMed ID: 8096629
    [No Abstract]   [Full Text] [Related]  

  • 28. The probenecid test.
    Korczyn AD
    J Neural Transm Suppl; 1983; 19():173-83. PubMed ID: 6142088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of serotonin storage and release.
    Sanders-Bush E
    Adv Biochem Psychopharmacol; 1982; 34():17-34. PubMed ID: 6127916
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimentally induced parkinsonism.
    Poirier LJ; Sourkes TL
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():416-33. PubMed ID: 4403656
    [No Abstract]   [Full Text] [Related]  

  • 31. Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells.
    Goldman SA
    Clin Pharmacol Ther; 2007 Oct; 82(4):453-60. PubMed ID: 17713467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New clues to the etiology of Parkinson disease: parkinsonism induced by the neurotoxin MPTP].
    Jonsson G; Sundström E
    Lakartidningen; 1986 Jan; 83(4):215-8. PubMed ID: 3485230
    [No Abstract]   [Full Text] [Related]  

  • 33. [Parkinson disease and the neuronal dopamine uptake complex].
    Costentin J
    Ann Pharm Fr; 1995; 53(4):145-54. PubMed ID: 7574268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycine receptors in the human brain: characterization of 3H-strychnine binding and status in pathological conditions.
    Lloyd KG; De Montis G; Javoy-Agid F; Beaumont K; Lowenthal A; Constantinidis J; Agid Y
    Adv Biochem Psychopharmacol; 1983; 36():233-8. PubMed ID: 6305150
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurochemical anatomy of movement disorders.
    Young AB; Penney JB
    Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phospholipid methylation and the synaptosomal uptake of mediator amino acids].
    Vartanian AA; Aprikian GV; Vaniushin BF
    Izv Akad Nauk SSSR Biol; 1990; (5):786-9. PubMed ID: 1980281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of l-vesamicol on transmitter release from rat motor nerve terminals at high frequencies of nerve stimulation.
    Prior C; Searl T; Marshall IG
    Br J Pharmacol; 1989 Dec; 98 Suppl():826P. PubMed ID: 2575420
    [No Abstract]   [Full Text] [Related]  

  • 38. Viral infections in the central nervous system and 5-hydroxytryptamine metabolism.
    Roos BE; Lycke E
    Adv Biochem Psychopharmacol; 1974; 11(0):115-7. PubMed ID: 4845694
    [No Abstract]   [Full Text] [Related]  

  • 39. New developments in the pathology of Parkinson's disease.
    Jellinger K
    Adv Neurol; 1990; 53():1-16. PubMed ID: 1978509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals.
    Bogen IL; Haug KH; Roberg B; Fonnum F; Walaas SI
    Neurochem Int; 2009; 55(1-3):13-21. PubMed ID: 19428802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.